Back

Role of ventricular tachycardia cycle length in the outcomes after catheter ablation or antiarrhythmic drugs in the SURVIVE-VT trial

31 August 2024 (13:15 - 13:25)
Organised by: Logo
Congress Presentation Part of: Sudden cardiac death: insight Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Pablo Avila Alonso

University Hospital Gregorio Maranon, Madrid (Spain)

5 More presentations in this session

Presentation thumbnail
High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: a multicenter cohort study and review of the literature
Mr M. Tukker (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Significance of J wave with inverted ST-T polarity induced by ill-timed atrial premature beats and its association with Torsade de Pointes in patients with acute acquired long QT syndrome
Doctor H. Ichiryu (Gifu, JP)
Abstract Slides Video
Presentation thumbnail
Comorbidities and use of proarrhythmic drugs in patients with torsade de pointes arrhythmia
Doctor K. Nowinski (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Prevalence and characteristics of the catecholamine induced QT prolongation syndrome
Professor V. Probst (Nantes, FR)
Abstract Slides Video
Presentation thumbnail
Identification of genetic variants by using a whole exome sequencing approach in Taiwanese patients with Brugada Syndrome
Doctor J. Juang (Taipei, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Sudden cardiac death: insight
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Session
Clinical Case Management: ventricular arrhythmias after myocardial infarction - patient-tailored treatment
thumbnail
Congress Presentation
Efficacy and safety of catheter ablation versus antiarrhythmic drug therapy in ventricular tachycardia management: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources